STAT

FEBRUARY 28, 2024

An expert panel advising the Centers for Disease Control and Prevention on vaccines on Wednesday recommended that people 65 and older should get an additional Covid-19 vaccine shot this spring. The recommendation was approved by CDC Director Mandy Cohen, allowing the United States to join Canada and the United Kingdom in offering a spring booster this year to people at high risk of severe disease if they contract Covid.

Vaccines 363

Vaccines 363

ALiEM - Pharm Pearls

FEBRUARY 28, 2024

As medical education podcasts, videos, and blogs continue to grow in popularity it is crucial that we cite them correctly, both in publications and on our CVs. We also must recognize the important contributions of media such as clinical photographs, radiology images, and ECGs. The American Medical Association (AMA) Manual of Style released its 11th edition in 2020.

130

130

STAT

FEBRUARY 28, 2024

In 2023, enrollment in Medicare Advantage, the version of Medicare run by private insurers, surpassed 50% of eligible beneficiaries for the very first time. Going by this headline, or perhaps the predictable flood of advertisements for plans during the fall’s open enrollment period, you might be fooled into thinking 2023 was MA’s best year yet.

363

363

PharmaVoice

FEBRUARY 28, 2024

From his advisory board role at Lindus Health, Robert Langer is aiming to overcome challenges in the CRO market.

147

147

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

FEBRUARY 28, 2024

Of all the lingering symptoms of long Covid , difficulty focusing and thinking, known as brain fog , may be the most frightening and baffling. A new study published Wednesday in the New England Journal of Medicine, which looks at how much cognition is impaired in the months after a coronavirus infection, shows that Covid-19’s impact can be measured in the equivalent of IQ points.

Hospitals 363

Hospitals 363

PharmaVoice

FEBRUARY 28, 2024

How research companies can shift strategies to attract and retain the staff that keeps trials humming along.

147

147

The Pharmacist

FEBRUARY 28, 2024

The new generation of pharmacists will not be satisfied with the ‘status quo’ of working in just one sector, Primary Care Pharmacy Association (PCPA) president Graham Stretch warned a community pharmacy conference this week. He warned contractors that younger pharmacists would ‘force our hands’ into creating multi-sector working opportunities. And he said that providers would […] The post Younger pharmacists want to work in multiple settings, says PCPA president appeared first on The Pharm

Community Pharmacies 115

Community Pharmacies 115

STAT

FEBRUARY 28, 2024

In a bid to combat prescription drug costs, the White House will hold a listening session on Monday in search of ways to reform pharmacy benefit managers , according to people familiar with the plans. The list of attendees includes representatives from the federal government and industry, who are expected to provide insights into how the largest pharmacy benefit managers determine which medicines are covered by insurers and employers, as well as prices that are paid at pharmacy counters.

342

342

pharmaphorum

FEBRUARY 28, 2024

Discover how digital technology and strategic partnerships are revolutionising the pharmaceutical industry, enabling faster delivery of life-saving medicines to patients, while advancing humanity's fight against diseases.

112

112

STAT

FEBRUARY 28, 2024

Elisabeth Bik, a microbiologist by training, has become one of the world’s most influential science detectives. An authority on scientific image analysis who’s been profiled in The New Yorker for her unique ability to spot duplicated or doctored photographs, she appeared frequently in the news over the past year as one of the experts who raised research misconduct concerns that led to an investigation into, and the eventual departure of, former Stanford president Marc Tessier-Lavig

340

340

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Express Pharma

FEBRUARY 28, 2024

Following the news that the FDA denied approval for Minerva Neurosciences for its roluperidone for the treatment of negative symptoms in patients with schizophrenia; Christie Wong, Neurology Analyst at GlobalData, offers her view: “The FDA has issued a Complete Response Letter (CRL) for Minerva Neurosciences’ roluperidone. It follows a refusal to file in October 2022 and two FDA Type C meetings in November 2020 and March 2022.

107

107

STAT

FEBRUARY 28, 2024

The 64 contestants whose discoveries and innovations have been selected for the 2024 edition of STAT Madness come from 50 institutions across the U.S. The teams include a Nobel laureate (Jennifer Doudna) and biotech big shots (Robert Langer and David Liu), but also up-and-comers. STAT Madness is our annual bracket-style competition in which readers vote on the most important and impactful biomedical and health research published in the past year by scientists at universities and independent labs

325

325

Pharmaceutical Technology

FEBRUARY 28, 2024

AGTC-501 is in Phase II development for retinitis in the SKYLINE trial (NCT03316560) and addresses unmet needs within the retinitis space

122

122

STAT

FEBRUARY 28, 2024

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry. It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic.

Drug Development 324

Drug Development 324

pharmaphorum

FEBRUARY 28, 2024

AbbVie has made another bolt-on deal in the immunology and inflammation category, paying $48 million upfront for rights to an antibody in preclinical development at OSE Immunotherapeutics. There’s another $665 million in potential milestones and a royalty tied to the deal, which focuses on OSE-230, billed as a potentially first-in-class activator of ChemR23, a G-protein coupled receptor (GPCR) found on some white blood cells.

104

104

STAT

FEBRUARY 28, 2024

LONDON — Facing a growing outbreak of measles, the U.K. has unveiled an advertising campaign aimed at boosting vaccination rates in children, which have steadily fallen over the past decade and took an even greater dip during the height of the Covid-19 pandemic. The campaign, starting March 4, features children talking about their lack of protection from infections like measles and whooping cough if they’re not vaccinated.

Immunity 302

Immunity Immunization Vaccines 302

Pharma Times

FEBRUARY 28, 2024

Breast cancer is responsible for around 47,000 new cases in England every year

144

144

STAT

FEBRUARY 28, 2024

In a global first, some travelers and laboratory researchers who are at risk of contracting chikungunya will soon be allowed to be vaccinated against the virus. A committee of vaccine experts recommended Wednesday that those selective groups of people should be offered access to the new vaccine, Ixchiq, which is made by Valneva Austria GmbH. It will become U.S. vaccination policy when Mandy Cohen, director of the Centers for Disease Control and Prevention, signs off on the recommendation from th

Vaccines 262

Vaccines Diabetes Immunity Immunization 262

pharmaphorum

FEBRUARY 28, 2024

Rare Disease Day is an opportunity to highlight the importance of enhancing clinical trial success in rare diseases for the benefit of patients.

114

114

STAT

FEBRUARY 28, 2024

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

Documentation 244

Documentation 244

GMPSOP

FEBRUARY 28, 2024

Basic cleaning and sanitation practices in Pharmaceuticals Pharmaceuticals quality assurance & validation procedures GMPSOP %title% Prev PREVIOUS POST Cleaning and sanitation of pharmaceutical equipment and facilities account for almost one-third of all production activities, if not more. Uncompromised safety and efficacy of pharmaceutical products are the best outcomes for the patients.

Documentation 98

Documentation Packaging Pharmaceutical Manufacturing Compounding 98

STAT

FEBRUARY 28, 2024

BETHESDA, Md. — President Joe Biden  “continues to be fit for duty,” his doctor wrote Wednesday after conducting an annual physical that is being closely watched as the 81-year-old  seeks reelection  in November. Dr. Kevin O’Connor, Biden’s physician, wrote that the president is adjusting well to a new device that helps control his sleep apnea and has experienced some hip discomfort but also works out five times per week.

240

240

Express Pharma

FEBRUARY 28, 2024

Zeno Health, an omnichannel platform for generic medicines, announced the successful closure of its Series C funding round, securing a total of $5 million. The round has been led by Korean private equity investor STIC Investments. Existing Zeno Health investor Lightbox was also a significant participant in the round. The company informed that the $25 million capital injection will be pivotal in propelling Zeno Health’s initiatives to reach more consumers, expand its footprint, and further

Generic Medicine 95

Generic Medicine 95

STAT

FEBRUARY 28, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a look at a resurgence in psychiatric drug development, a big day for biotech stocks, and some innovation in the world of quarterly earnings.

Drug Development 216

Drug Development Drug Pricing 216

pharmaphorum

FEBRUARY 28, 2024

Peterson Health Technology Institute will review the clinical effectiveness and economic impact of digital health technologies (DHTs) for hypertension and mental health.

97

97

Express Pharma

FEBRUARY 28, 2024

Orphan diseases, also known as rare diseases, are a variety of conditions that affect a small percentage of the population. By definition, rare diseases are those diseases with a prevalence rate of one case in a population of 10,000 people. Rare diseases are of two types: primary and secondary. Primary rare diseases are caused due to genetic or congenital defects.

Drug Development 90

Drug Development 90

pharmaphorum

FEBRUARY 28, 2024

Viatris licenses two late-stage drugs from Idorsia for heart attack and lupus, both claimed to have blockbuster sales potential, for $350m upfront.

100

100

Pharmaceutical Technology

FEBRUARY 28, 2024

Pelage Pharmaceuticals has secured $16.75m in a Series A financing round to further the development of PP405 for hair loss.

104

104

pharmaphorum

FEBRUARY 28, 2024

Buoyed by data from a trial of its T-cell engager (TCE) therapy in prostate cancer that almost tripled its share price, Janux Therapeutics has moved quickly to file a stock offering that could add around $200 million to its cash position. The San Diego biotech is offering $175 million in a public offering that could rise to $201.5 million if underwriters take up an option, less discounts and commissions.

85

85

Pharmaceutical Technology

FEBRUARY 28, 2024

Amneal has signed an agreement with Zambon Biotech for IPX203 for the treatment of Parkinson's disease (PD) in certain regions.

98

98

The Pharmacist

FEBRUARY 28, 2024

Shadow health secretary Wes Streeting has promised that Labour will make use of community pharmacy’s ‘untapped potential’ if it wins the next general election, pledging to increase the sector’s involvement in the management of long-term conditions and tackling overprescribing. Speaking via video link at the Sigma Conference, Mr Streeting said Labour would also put pharmacists […] The post Streeting: Labour will tap potential of ‘undervalued’ pharmacists appeared first on The Pharmacist.

Community Pharmacies 88

Community Pharmacies 88

Pharmaceutical Technology

FEBRUARY 28, 2024

The Phase III VELA programme will compare the IL-17 inhibitor sonelokimab to a placebo, enrolling 800 patients over 52 weeks.

100

100

European Pharmaceutical Review

FEBRUARY 28, 2024

A study published in the Asian Journal of Advanced Research and Reports , has reported “a strong positive correlation between higher levels of regulatory compliance and perceived effectiveness in artificial intelligence (AI) implementation, as well as between AI ethics awareness and data integrity assurance.” The research highlighted the importance of regulatory frameworks and professional training in shaping AI development, specifically “dynamic, adaptable, and inclusive regulatory frameworks t

78

78

Pharmaceutical Technology

FEBRUARY 28, 2024

As post-approval boundaries disproportionately affect rare disease patients, communities are rallying behind alternative options.

98

98

Pharma Times

FEBRUARY 28, 2024

The inherited fatal heart muscle condition affects one in every 500 adults in the UK

105

105